Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: Taiwan Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20052
20062
20072
20082
20092
20103
20113
20123
20131
20143
20153
20161
20171
20191
20201
20222
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim9
GlaxoSmithKline8
AstraZeneca7
Novartis Pharmaceuticals6
Sanofi3
Hoffmann-La Roche2
Pearl Therapeutics, Inc.2
Chiesi Farmaceutici S.p.A.1
Eli Lilly and Company1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive41
Diabetes Mellitus2
Asthma1
Bronchial Diseases1
Cardiovascular Diseases1
Diabetes Mellitus, Type 11
Diabetes Mellitus, Type 21
Lung Diseases1
Lung Diseases, Obstructive1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.